Is Trinity Biotech plc (ADR) (TRIB) A Good Stock To Buy?

As one would reasonably expect, some big names were breaking ground themselves. Adage Capital Management, led by Phill Gross and Robert Atchinson, initiated the most outsized position in Trinity Biotech plc (ADR) (NASDAQ:TRIB). Adage Capital Management had $1.3 million invested in the company at the end of the quarter.

Let’s also examine hedge fund activity in other stocks similar to Trinity Biotech plc (ADR) (NASDAQ:TRIB). We will take a look at CONN’S, Inc. (NASDAQ:CONN), Bridgepoint Education Inc (NYSE:BPI), Natural Health Trends Corp. (NASDAQ:NHTC), and Tuniu Corp (NASDAQ:TOUR). All of these stocks’ market caps resemble TRIB’s market cap.

As you can see these stocks had an average of 11 hedge funds with bullish positions and the average amount invested in these stocks was $42 million. That figure was $57 million in TRIB’s case. CONN’S, Inc. (NASDAQ:CONN) is the most popular stock in this table. On the other hand Tuniu Corp (NASDAQ:TOUR) is the least popular one with only 7 bullish hedge fund positions. Compared to these stocks Trinity Biotech plc (ADR) (NASDAQ:TRIB) is more popular among hedge funds. Considering that hedge funds are fond of this stock in relation to its market cap peers, it may be a good idea to analyze it in detail and potentially include it in your portfolio.

Disclosure: None